HOOK HOOKIPA Pharma Inc. Stock Quote

HOOK [NASD]

Index	-	P/E	-	EPS (ttm)	-1.63	Insider Own	0.40%	Shs Outstand	25.66M	Perf Week	13.27%
Market Cap	397.44M	Forward P/E	-	EPS next Y	-2.31	Insider Trans	-39.78%	Shs Float	14.36M	Perf Month	3.91%
Income	-41.90M	PEG	-	EPS next Q	-0.59	Inst Own	47.30%	Short Float	8.25%	Perf Quarter	27.72%
Sales	18.00M	P/S	22.08	EPS this Y	-277.10%	Inst Trans	-0.01%	Short Ratio	10.98	Perf Half Y	3.39%
Book/sh	3.59	P/B	3.40	EPS next Y	-24.20%	ROA	-31.30%	Target Price	-	Perf Year	1.33%
Cash/sh	2.51	P/C	4.86	EPS next 5Y	4.80%	ROE	-39.60%	52W Range	5.80 - 14.37	Perf YTD	10.10%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-41.50%	52W High	-11.04%	Beta	-
Dividend %	-	Quick Ratio	5.70	Sales past 5Y	-	Gross Margin	-	52W Low	120.34%	ATR	0.69
Employees	85	Current Ratio	5.70	Sales Q/Q	100.00%	Oper. Margin	-	RSI (14)	64.53	Volatility	6.98% 5.86%
Optionable	Yes	Debt/Eq	0.05	EPS Q/Q	-18.20%	Profit Margin	-	Rel Volume	0.98	Prev Close	12.21
Shortable	Yes	LT Debt/Eq	0.05	Earnings	Nov 12 BMO	Payout	-	Avg Volume	107.91K	Price	12.78
Recom	1.60	SMA20	12.06%	SMA50	11.67%	SMA200	23.27%	Volume	105,523	Change	4.67%

Nov-03-20

Initiated

Truist

Buy

$21

Oct-26-20

Initiated

JMP Securities

Mkt Outperform

$19

Oct-19-20

Resumed

H.C. Wainwright

Buy

$16

Sep-27-19

Initiated

H.C. Wainwright

Buy

$15

May-13-19

Initiated

RBC Capital Mkts

Outperform

$23

May-13-19

Initiated

BofA/Merrill

Buy

$17

Jan-20-21 09:55AM	HOOKIPA Pharma (HOOK) in Focus: Stock Moves 8.4% Higher Zacks
Dec-11-20 04:20PM	HOOKIPA Pharma Announces Closing of Public Offering of $80.9 Million of Common Stock and Preferred Stock, Including Full Exercise of Underwriters Option GlobeNewswire
Dec-08-20 10:00PM	HOOKIPA Pharma Announces Pricing of Public Offering of Common Stock and Preferred Stock GlobeNewswire +11.36%
04:01PM	HOOKIPA Pharma Announces Proposed Public Offering of Common Stock and Preferred Stock GlobeNewswire
08:34AM	HOOKIPA (HOOK) Surges: Stock Moves 8.6% Higher Zacks
Dec-07-20 11:33PM	Is HOOK A Good Stock To Buy Now? Insider Monkey +8.61%
06:00AM	HOOKIPA Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability GlobeNewswire
Nov-30-20 06:00AM	HOOKIPA Announces Positive Phase 2 Interim Safety, Immunogenicity, and Efficacy Data for its Cytomegalovirus Vaccine Candidate HB-101 GlobeNewswire
Nov-18-20 10:23AM	New Strong Sell Stocks for November 18th Zacks
Nov-15-20 08:26AM	HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Are Pretty Bullish On The Stock After Recent Results Simply Wall St.
Nov-12-20 07:39AM	HOOKIPA Pharma: Q3 Earnings Insights Benzinga
07:15AM	HOOKIPA Pharma Reports Third Quarter 2020 Financial Results and Provides a Corporate Update GlobeNewswire
Nov-11-20 07:00AM	HOOKIPA Pharma to Participate in Upcoming Investor Conferences in November GlobeNewswire
Nov-03-20 07:00AM	HOOKIPA Pharma To Report Third Quarter 2020 Financial Results on November 12, 2020 GlobeNewswire +12.32%
Oct-29-20 07:30AM	HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-202/HB-201 Alternating Vector Therapy to Treat Human Papillomavirus 16-Positive Cancers GlobeNewswire +6.33%
Oct-26-20 10:08AM	Benzinga's Top Upgrades, Downgrades For October 26, 2020 Benzinga
Oct-21-20 10:32AM	Is HOOKIPA Pharma (NASDAQ:HOOK) Using Debt In A Risky Way? Simply Wall St.
Oct-19-20 08:00AM	HOOKIPA Appoints Prof. Jean-Charles Soria, Director General of the Gustave Roussy Cancer Center in Paris, to its Board of Directors GlobeNewswire
Sep-16-20 07:45AM	HOOKIPA Pharmas LCMV-based Immunotherapy for HPV16+ Cancers Demonstrates High Immunogenicity, According to Peer Reviewed Article GlobeNewswire +5.91%
07:00AM	HOOKIPA Pharma to Present at SVB Leerinks CybeRx Series Vaccine Forum GlobeNewswire
Sep-09-20 07:30AM	HOOKIPA Pharma to Present at Upcoming Conferences in September GlobeNewswire
Aug-13-20 10:35AM	HOOKIPA Pharma Inc. (HOOK) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:20AM	Recap: HOOKIPA Pharma Q2 Earnings Benzinga
07:00AM	HOOKIPA Pharma Reports Second Quarter 2020 Financial Results and Provides a Corporate Update GlobeNewswire
Aug-06-20 12:30PM	HOOKIPA Pharma Inc. (HOOK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Aug-04-20 07:00AM	HOOKIPA Pharma To Report Second Quarter 2020 Financial Results on August 13, 2020 GlobeNewswire
Aug-03-20 12:31PM	HOOKIPA Pharma Inc. (HOOK) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
07:00AM	HOOKIPA Announces Issuance of US and European Patents GlobeNewswire
Jul-23-20 03:24PM	Could The HOOKIPA Pharma Inc. (NASDAQ:HOOK) Ownership Structure Tell Us Something Useful? Simply Wall St.
Jun-22-20 07:15AM	HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB101 GlobeNewswire
Jun-19-20 07:00AM	HOOKIPA Announces Changes to its Board of Directors Resignation of Sander van Deventer GlobeNewswire
Jun-17-20 07:00AM	HOOKIPA Announces FDA Clearance of its IND Application for HB-202/201 Clinical Trial to Treat HPV-Positive Cancers GlobeNewswire
Jun-12-20 02:04PM	Hedge Funds Are Selling HOOKIPA Pharma Inc. (HOOK) Insider Monkey +9.03%
Jun-11-20 08:34AM	Why HOOKIPA (HOOK) Stock Might be a Great Pick Zacks -10.92%
May-26-20 07:30AM	HOOKIPA Pharma to Present at Jefferies Virtual Healthcare Conference GlobeNewswire
May-17-20 09:31AM	HOOKIPA Pharma Inc. (NASDAQ:HOOK) First-Quarter Results: Here's What Analysts Are Forecasting For This Year Simply Wall St.
May-14-20 08:15AM	HOOKIPA Pharma Inc (HOOK) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:00AM	HOOKIPA Pharma Reports First Quarter 2020 Financial Results and Provides a Corporate Update GlobeNewswire
May-07-20 12:30PM	Will HOOKIPA Pharma Inc (HOOK) Report Negative Earnings Next Week? What You Should Know Zacks
May-04-20 07:00AM	HOOKIPA Pharma To Report First Quarter 2020 Financial Results on May 14, 2020 GlobeNewswire +5.65%
Apr-29-20 07:00AM	HOOKIPA Pharma to Present at Upcoming Conferences in May GlobeNewswire
Apr-21-20 07:00AM	HOOKIPA Pharma Announces Publication of HB-101 Phase 1 Results in The Journal of Infectious Diseases GlobeNewswire -5.60%
Apr-19-20 10:33AM	Did Changing Sentiment Drive HOOKIPA Pharma's (NASDAQ:HOOK) Share Price Down By 43%? Simply Wall St.
Mar-19-20 07:00AM	HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update GlobeNewswire -9.00%
06:00AM	HOOKIPA Pharma, Inc. to Host Earnings Call ACCESSWIRE
Mar-10-20 08:15AM	HOOKIPA Pharma To Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 19, 2020 GlobeNewswire
Feb-18-20 08:00AM	HOOKIPA Pharma to Present at SVB Leerink 9th Annual Global Healthcare Conference GlobeNewswire
Jan-15-20 09:53AM	Is HOOKIPA Pharma (NASDAQ:HOOK) Using Debt In A Risky Way? Simply Wall St.
Jan-06-20 07:00AM	HOOKIPAs Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry GlobeNewswire
Dec-30-19 07:30AM	HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers GlobeNewswire
Dec-20-19 02:27PM	Hedge Funds Have Never Been This Bullish On HOOKIPA Pharma Inc. (HOOK) Insider Monkey +5.95%
Nov-25-19 08:00AM	HOOKIPA Pharma to Present at Piper Jaffray 31st Annual Healthcare Conference GlobeNewswire
Nov-12-19 04:01PM	HOOKIPA Pharma Reports Third Quarter 2019 Financial Results and Provides a Corporate Update GlobeNewswire
Nov-04-19 08:00AM	HOOKIPA Pharma To Report Third Quarter 2019 Financial Results on November 12, 2019 GlobeNewswire -5.52%
Oct-31-19 08:15AM	HOOKIPA Pharma to Present at Upcoming Conferences in November GlobeNewswire
Sep-25-19 08:30AM	HOOKIPA Announces Key Hires to its Executive Team GlobeNewswire
Sep-19-19 08:55AM	HOOKIPA to Present Data Demonstrating the Potential of its TheraT® Technology at the Upcoming CICON Conference in Paris GlobeNewswire
Aug-29-19 08:30AM	HOOKIPA Pharma to Present at Upcoming Investor Conferences in September GlobeNewswire +9.44%
Aug-12-19 04:01PM	HOOKIPA Pharma Reports Second Quarter 2019 Financial Results and Clinical Progress Highlights GlobeNewswire
Jul-19-19 01:37PM	What Kind Of Shareholders Own HOOKIPA Pharma Inc. (NASDAQ:HOOK)? Simply Wall St. +5.31%
Jul-17-19 10:06AM	Biotech Stock Roundup: Galapagos & Hookipa Surge, AMGN Shelves Alzheimer's Study Zacks +10.77%
Jul-12-19 07:58AM	Dow Jones Futures: Illumina, Profitable Marijuana Stock Tumble; Amgen-Novartis Alzheimer's Drug Fails Investor's Business Daily +22.90%
07:24AM	The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study Benzinga
Jul-11-19 04:37PM	Hookipa Pharma jumps 40% after FDA approval of clinical tests MarketWatch
04:01PM	HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers GlobeNewswire
02:05PM	[video]Hookipa Soars on FDA OK of Early Stage Trial For Cancer Treatment TheStreet.com
Jun-10-19 09:10AM	CEO of Agrios Global Holdings Ltd. Presenting at The Advantage Strategy and Financial Conference June 14, 2019, in Vienna, Austria CNW Group +7.28%
May-20-19 04:01PM	HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights GlobeNewswire
May-08-19 03:47AM	HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead GlobeNewswire
Apr-25-19 08:30AM	HOOKIPA Appoints David R. Kaufman to its Board of Directors GlobeNewswire
Apr-18-19 11:01AM	Hookipa Pharma shares off to lackluster start in trading debut MarketWatch
07:26AM	5 things to know about Hookipa Pharma ahead of its IPO MarketWatch
Apr-17-19 10:49PM	HOOKIPA Pharma Announces Pricing of Initial Public Offering GlobeNewswire
Apr-14-19 09:53AM	IPO Outlook For The Week: Pinterest, Zoom, Biotechs, Minerals And Catastrophe Insurance Benzinga

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immune-therapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop infectious disease product candidates intended to support functional cures for chronic Hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Matushansky Igor	Chief Medical Officer	Dec 17	Option Exercise	0.10	48,988	4,899	93,881	Dec 18 04:04 PM
Matushansky Igor	Chief Medical Officer	Dec 17	Sale	11.74	27,979	328,343	64,253	Dec 18 04:04 PM
Matushansky Igor	Chief Medical Officer	Dec 16	Option Exercise	0.10	640	64	56,774	Dec 18 04:04 PM
Matushansky Igor	Chief Medical Officer	Dec 16	Sale	11.70	380	4,446	56,394	Dec 18 04:04 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Oct 02	Sale	10.00	300	3,000	3,906,194	Oct 06 04:01 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Sep 15	Sale	12.61	41,597	524,477	3,906,494	Sep 17 04:02 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Jul 20	Sale	11.94	12,483	149,102	3,948,091	Jul 22 04:03 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Jun 29	Sale	11.78	3,280	38,628	3,960,574	Jul 01 04:16 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Jun 29	Sale	11.78	3,280	38,628	3,960,574	Jul 22 04:03 PM
Matushansky Igor	Chief Medical Officer	Jan 29	Sale	12.73	5,500	69,992	53,398	Jan 31 04:01 PM
Lilja Anders	Sr. VP, Technical Development	Jan 23	Option Exercise	0.10	11,643	1,164	7,568	Jan 27 04:52 PM
Lilja Anders	Sr. VP, Technical Development	Jan 23	Sale	12.59	11,643	146,533	0	Jan 27 04:52 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience